Health & Medicine
-
Tobacco Plants Used to Develop a COVID-19 Vaccine
In an interview conducted by Technology Networks to the Scientific Research Director of British American Tobacco (BAT), David O'Reilly, PhD, it was confirmed that there was an undergoing preclinical testing for COVID-19 vaccine using tobacco plant as a "biomanufacturing factory". This simply means that tobacco plants were being used as a vessel where a key protein from the coronavirus is being processed so that it can be used in developing a vaccine.
Latest Research Articles
-
Countries Who Will Fail to Cut Reliance in Coal Will "Hear From the US"
-
Plastics Used as Biodegradable Surfactant: Good or Bad Sustainability Solution?
-
Human to Nonhuman Chimeras Discussion Resurfaces After Monkey Embryos Established to Have Human Cells
-
AI and Satellites Can Help Identify Pollution Hotspots, Researchers Show
-
Magic Mushroom Compound Can Be the Future Treatment for Depression
-
Carbon Cutting: 3 Innovative Ideas To Reduce Harmful Emission
-
Humans 10x Better Than Chimps and Macaques When It Comes to Temperature Control
-
France Aims to Cut Emissions By Banning Short Flights
-
To Achieve Climate Goal, China Must Shut Down 600 Coal-Fired Plants Within 10 Years
-
Covid Particles in the Dust May Help Predict Potential Outbreaks
-
3 Important Things to Remember When Purifying Water at Home
Study Shows How Road Salts and Other Man-Made Materials Actually Harms Freshwater Sources
MOST POPULAR
-
How Wildlife Corridors Create Lifelines for Animals Facing Habitat Loss and Fragmentation
-
Why Are Coral Reefs Bleaching Faster Than Ever—and Can They Actually Recover?
-
How Community Conservation Programs Protect Wildlife and Build Sustainable Futures for Everyone
-
Safeguarding the Wild: National Parks That Shield Earth's Rarest Animals
-
Antarctica Hidden Mountains: Stunning Map Reveals Secret Peaks Under Ice Sheet
